Epigenetic Modulation of Type 2 Immune Responses in Allergic Disorders: A Longitudinal Systems Biology Approach

Authors

  • Suningsih Suabey Suningsih Suabey, Wamena School of Nursing, Jayapura Health Polytechnic, Ministry of Health Republic of Indonesia, Papua, Indonesia Author
  • Agussalim Agussalim, Parepare School of Nursing, Makassar Health Polytechnic, Ministry of Health Republic of Indonesia, Makassar, Indonesia Author

DOI:

https://doi.org/10.47363/1j6e2k12

Keywords:

Epigenetics, DNA Methylation, Histone Modification, Type 2 Immunity, Allergic Disorders

Abstract

Background: Allergic disorders are among the fastest-growing chronic inflammatory diseases worldwide, affecting more than one billion individuals. Although genetic susceptibility contributes to disease development, it cannot fully explain the increasing prevalence of allergic conditions. Epigenetic mechanisms, including DNA methylation, histone modification, chromatin remodeling, and non-coding RNA regulation, have emerged as key mediators linking environmental exposures to dysregulated Type 2 immune responses.

Objective: This study investigated longitudinal epigenetic remodeling associated with Type 2 immune responses in allergic disorders using an integrated multi-omics systems biology approach and identified epigenetic signatures associated with disease progression and therapeutic responsiveness.

Methods: A multicenter longitudinal study was conducted between April 2023 and October 2025 in tertiary hospitals across Indonesia. Five hundred adults with clinically confirmed allergic disorders were followed for 24 months. Genome-wide DNA methylation, histone acetylation, transcriptomic profiling, and Type 2 inflammatory biomarkers, including IL-4, IL-5, IL-13, eosinophils, and total IgE, were analyzed. Longitudinal mixed-effects regression and systems biology analyses evaluated temporal associations between epigenetic alterations and immune dysregulation.

Results: Significant hypomethylation of IL4 and IL13 promoters was associated with increased cytokine expression (β = −0.41, p < 0.001). Enhanced H3K27 acetylation correlated with increased chromatin accessibility and Type 2 cytokine transcription. Greater epigenetic remodeling was associated with higher disease severity, recurrent exacerbations, delayed therapeutic responses, and persistent eosinophilic inflammation.

Conclusion: Longitudinal epigenetic remodeling is a key regulator of Type 2 immunity and may support biomarker discovery and precision medicine for allergic disorders

Downloads

Published

2026-10-26